Cargando…
Plasma Interleukin-6 Level Predicts the Risk of Arteriovenous Fistula Dysfunction in Patients Undergoing Maintenance Hemodialysis
Systemic inflammation has been proposed as a relevant factor of vascular remodeling and dysfunction. We aimed to identify circulating inflammatory biomarkers that could predict future arteriovenous fistula (AVF) dysfunction in patients undergoing hemodialysis. A total of 282 hemodialysis patients we...
Autores principales: | Baek, Jihyun, Lee, Hyeyeon, Yang, Taeyoung, Lee, So-Young, Kim, Yang Gyun, Kim, Jin Sug, Ahn, ShinYoung, Kim, Kipyo, Kang, Seok Hui, Lee, Min-Jeong, Lee, Dong-Young, Jeong, Hye Yun, Lee, Yu Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864732/ https://www.ncbi.nlm.nih.gov/pubmed/36675812 http://dx.doi.org/10.3390/jpm13010151 |
Ejemplares similares
-
Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis
por: Moon, Ju-Young, et al.
Publicado: (2015) -
Administration of a High-Dose Erythropoietin-Stimulating Agent in Hemodialysis Patients is Associated with Late Arteriovenous Fistula Failure
por: Jeong, Hye Yun, et al.
Publicado: (2017) -
Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients
por: Hwang, Hyeon Seok, et al.
Publicado: (2020) -
Plasma Endocan as a Predictor of Cardiovascular Event in Patients with End-Stage Renal Disease on Hemodialysis
por: Kim, Jin Sug, et al.
Publicado: (2020) -
Pre-existing arterial pathologic changes affecting arteriovenous fistula patency and cardiovascular mortality in hemodialysis patients
por: Lee, Ja Young, et al.
Publicado: (2017)